from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3679/-

LFCtreatmentdescriptionclass of inhibitor

0.464

Amikacinug/mL Amikacintranslation

0.641

Cap5-10ug/mL Capreomycintranslation

1.734

Rox10-50 ug/mL Roxithromycintranslation

0.704

SM2-5 ug/mL Streptomycintranslation

0.954

Tet5-10 ug/mL Tetracyclinetranslation

-0.362

Rif0.2-5ug/mL Rifampicintranscription

-1.234

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.472

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.094

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.722

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.457

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.025

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.306

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.005

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.410

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.013

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.056

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.822

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.345

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.252

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.615

KCN5-20 ug/mL Potassium cyaniderespiration

0.068

NaN30.2-2 mM Sodium aziderespiration

1.249

Nigericin50 uM Nigericinrespiration

0.056

TRC10-150 ug/mL Triclosanrespiration

-1.980

TRZ10-25 ug/mL Thioridazinerespiration

-0.741

Valinomycin0.5-10 uM Valinomycinrespiration

2.935

ZnSO42 mM ZnSO4respiration

-0.229

menadione6-10 ug/mL Menadionerespiration

0.142

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.374

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.167

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.198

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.087

NRP_1Non-replicating persistence stage 1dosRassociated

0.024

Amp0.2mg/mL AmpicillincellWall

0.394

Cephalexin20-100 ug/mL CephalexincellWall

0.464

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.043

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.090

EMB10-20 ug/mL EthambutolcellWall

0.425

Eta12-40 ug/mL EthionamidecellWall

1.235

INH0.2-0.4 ug/mL IsoniazidcellWall

0.109

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.046

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.092

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.658

BZA0.12 mg/mL BenzamidearomaticAmides

0.123

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.239

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.493

H2O24 mM hydrogen peroxideDNAdamaging

1.041

Levo10 ug/mL LevofloxacinDNAdamaging

-0.463

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.253

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.091

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.015

UVUV-irradiationDNAdamaging

-1.126

ARP41-4 ug/mL Antitubercular compound ARP4?

0.035

Antimycin12.5-50 ug/mL Antimycin A?

0.644

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.455

PA_110-50 ug/mL Antitubercular compound PA-1?

0.096

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.011

PA8240.2-2 ug/mL PA-824?

0.035

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.408

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.037

Verapamil50 uM Verapamil?

0.035

mercaptoethanol2 mM 2-Mercaptoethanol?

0.790

methoxatin10-20 ug/mL Methoxatin?